Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$601M |
| 2 |
Moderna
MRNA
|
+$557M |
| 3 |
Analog Devices
ADI
|
+$448M |
| 4 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$445M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$406M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$652M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$512M |
| 3 |
TSMC
TSM
|
+$378M |
| 4 |
JPMorgan Chase
JPM
|
+$318M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Financials | 12.68% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Communication Services | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Primis Financial Corp
FRST
$406M
| $3.01M | ﹤0.01% |
208,011
-8,438
| -4% | -$126K |
|
3052
Arbutus Biopharma
ABUS
$873M
| $3M | ﹤0.01% |
700,504
-18,655
| -3% | -$62.2K |
|
|
SMMF
3053
DELISTED
Summit Financial Group, Inc.
SMMF
| $3M | ﹤0.01% |
122,580
-3,313
| -3% | -$77.4K |
|
3054
KRONOS Worldwide
KRO
$709M
| $2.98M | ﹤0.01% |
239,945
-16,703
| -7% | -$221K |
|
3055
Vanguard Financials ETF
VFH
$13.6B
| $2.98M | ﹤0.01% |
32,144
+7,381
| +30% | +$681K |
|
|
AMPE
3056
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $2.98M | ﹤0.01% |
5,981
-187
| -3% | -$86.7K |
|
3057
ClearPoint Neuro
CLPT
$460M
| $2.98M | ﹤0.01% |
167,655
-8,771
| -5% | -$164K |
|
3058
BeyondSpring
BYSI
$48.9M
| $2.96M | ﹤0.01% |
188,077
-29,641
| -14% | -$533K |
|
|
CFLT
3059
DELISTED
Confluent
CFLT
| $2.96M | ﹤0.01% |
+49,694
| New | +$2.58M |
|
|
APLT
3060
DELISTED
Applied Therapeutics
APLT
| $2.96M | ﹤0.01% |
178,200
-11,804
| -6% | -$204K |
|
3061
Peoples Financial Services
PFIS
$706M
| $2.95M | ﹤0.01% |
64,834
-1,573
| -2% | -$69.9K |
|
3062
Payoneer
PAYO
$2.41B
| $2.95M | ﹤0.01% |
+344,948
| New | +$3.35M |
|
3063
Krispy Kreme
DNUT
$543M
| $2.95M | ﹤0.01% |
+210,445
| New | +$3.38M |
|
3064
Aveanna Healthcare
AVAH
$2.11B
| $2.94M | ﹤0.01% |
366,826
-42,585
| -10% | -$413K |
|
|
NOAH
3065
Noah Holdings
NOAH
$578M
| $2.94M | ﹤0.01% |
79,108
-127,922
| -62% | -$5.07M |
|
3066
Ecopetrol
EC
$34.3B
| $2.93M | ﹤0.01% |
204,425
-261,275
| -56% | -$3.55M |
|
|
SWI
3067
DELISTED
SolarWinds Corporation Common Stock
SWI
| $2.93M | ﹤0.01% |
175,323
-118,774
| -40% | -$2.2M |
|
3068
Gerdau
GGB
$9.7B
| $2.93M | ﹤0.01% |
749,933
-61,899
| -8% | -$269K |
|
|
EBET
3069
DELISTED
EBET, INC. Common Stock
EBET
| $2.92M | ﹤0.01% |
2,901
+2,809
| +3,053% | +$2.27M |
|
3070
Donegal Group Class A
DGICA
$740M
| $2.92M | ﹤0.01% |
201,580
-8,087
| -4% | -$122K |
|
|
ESTE
3071
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $2.92M | ﹤0.01% |
317,394
-1,620
| -0.5% | -$14.9K |
|
|
FUV
3072
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $2.92M | ﹤0.01% |
12,769
-536
| -4% | -$146K |
|
3073
Vanguard ESG International Stock ETF
VSGX
$6.52B
| $2.91M | ﹤0.01% |
47,171
| – | – |
|
3074
Preformed Line Products
PLPC
$1.75B
| $2.91M | ﹤0.01% |
44,767
-1,362
| -3% | -$96K |
|
3075
Spyre Therapeutics
SYRE
$8.39B
| $2.91M | ﹤0.01% |
14,628
-106
| -0.7% | -$18.5K |
|
Similar funds
Northern Trust's Q3 2021 Portfolio in Review
As of Q3 2021, Northern Trust held 4,828 positions worth $565B, down 0.48% from $568B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Northern Trust's Q3 2021 filing shows 242 new, 1,428 increased, 2,705 reduced and 176 closed positions. Its largest new stake was Dimensional International Value ETF: 4,656,805 shares worth $152M. The largest sale was Alphabet (Google) Class C, an estimated $652M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q3 2021 buy was Dimensional International Value ETF: 4,656,805 shares worth $152M.
- Northern Trust added most to Johnson & Johnson in Q3 2021, an estimated $601M increase.
- Northern Trust's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $652M.
- Northern Trust fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $512M.
- Northern Trust's ten largest holdings make up 22% of its $565B portfolio in Q3 2021.
- Northern Trust opened 242 new positions and closed 176 in Q3 2021.
- Northern Trust's portfolio value fell 0.48% quarter-over-quarter to $565B.
Based on Northern Trust's 13F filing for Q3 2021, filed 15 Nov 2021.